Clinical Trials
The effectiveness of Boston Scientific pain management solutions have been proven in a number of important clinical trials. Below you can find information about upcoming clinical trials focused on pain management.
The FAST™ Study
Chronic pain affects 1 in 5 adults, and can impact nearly every aspect of daily life - from work performance, to family life, to social interactions.1 For many people, this pain affects the lower back and/or legs, and can be caused by a variety of underlying conditions.
If you’ve struggled with chronic low back and/or leg pain for at least 6 months that has not responded to other treatments, you may be a candidate for the FAST Study. The study uses the WaveWriter™ Spinal Cord Stimulator System - an FDA-approved, drug-free therapy shown to effectively relieve chronic pain and improve quality of life.2,3
The SCOPE Study
If you’ve been living with dull or aching leg pain, numbness or cramping (with or without back pain), you may have lumbar spinal stenosis (LSS) - and you have options. One option is the Vertiflex™ Procedure†, a minimally-invasive medical solution that can help treat the root cause of LSS. The Vertiflex Procedure offers a safe and effective alternative to more invasive surgical options, with most people returning home the same day they receive the Vertiflex Procedure.
The Vertiflex Procedure is currently being offered at select US centers through a new clinical research study called the SCOPE Study. If you qualify and choose to join the SCOPE Study you will be treated by a local physician specialist, and will be compensated for your time and travel for attending follow-up visits to evaluate your progress.
†Superion™ Indirect Decompression System.
References: 1. Dahlhamer J, Lucas J, Zelaya, C, et al. Prevalence of Chronic Pain and High-Impact Chronic Pain Among Adults — United States, 2016. MMWR Morb Mortal Wkly Rep 2018;67:1001–1006. 2. Veizi E, Hayek SM, North J, et al. Spinal cord stimulation (SCS) with anatomically guided (3D) neural targeting shows superior chronic axial low back pain relief compared to traditional SCS—LUMINA Study. Pain Med. 2017;18(8):1534-1548. 3. Thomson SJ, Kruglov D, Duarte RV. A spinal cord stimulation service review from a single centre using a single manufacturer over a 7.5 year follow-up period. Neuromodulation. 2017;20(6):589-599. N=321